Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
1 study found for:    JVBT
Show Display Options
Rank Status Study
1 Completed
Has Results
A Study of Ramucirumab in Participants With Gastric, Esophageal, and Gastroesophageal Cancer
Conditions: Stomach Cancer;   Esophageal Cancer
Interventions: Biological: Ramucirumab;   Drug: Placebo;   Drug: Oxaliplatin;   Drug: Leucovorin;   Drug: 5-Fluorouracil

Study has passed its completion date and status has not been verified in more than two years.